Evidence map›Paper›PMID 36726540›Full record

ArticleOpen forum infectious diseases2023

Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIV.

Jennifer A Manuzak, Janeway Granche, Katherine Tassiopoulos, Joseph E Rower, Justin R Knox, Dionna W Williams, Ronald J Ellis, Karl Goodkin, Anjali Sharma, Kristine M Erlandson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Changes in cannabis use post decriminalisation in mental health care users in South Africa.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2025
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 1 country.

Jennifer A ManuzakDivision of Immunology, Tulane National Primate Research Center, Covington, Louisiana, USA.ORCID https://orcid.org/0000-0002-0079-2306
Janeway GrancheCenter for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Katherine TassiopoulosDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Joseph E RowerCenter for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, USA.
Justin R KnoxDepartment of Psychiatry, Columbia University, Irving Medical Center, New York, New York, USA.
Dionna W WilliamsDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ronald J EllisDepartment of Neurosciences, University of California, San Diego, La Jolla, California, USA.
Karl GoodkinConsultant, AIDS Clinical Trials Group, Los Angeles, California, USA.
Anjali SharmaDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Kristine M ErlandsonDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
AIDS Clinical Trials Group (ACTG) A5322 Study Team
AIDS Clinical Trials Group · USAlbert Einstein College of Medicine · USCancer Research And Biostatistics · USColumbia University Irving Medical Center · USHarvard University · USJohns Hopkins University · USTulane University · USUniversity of California San Diego · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Utah · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit 2024 SupplementUM1AI069423 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, MINA CHRISTINE HOSSEINIPOUR · 2012 to 2026
$71.8M
UCSD Department of Medicine HIV/AIDS Clinical Trials UnitUM1AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TIMOTHY J. WILKIN · 2012 to 2026
$50.4M
Mechanisms of Innate Immune Dysfunction in Siv/Malaria Co-infection in PregnancyR01HD108015 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI MANUZAK, JENNIFER · 2021 to 2025
$4.7M
Cannabis use, PrEP and HIV transmission risk Among Black MSM in ChicagoR01DA054553 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DUNCAN, DUSTIN T, KNOX, JUSTIN · 2021 to 2025
$3.6M
Intervening to improve HIV treatment and reduce drinking in young, black men who have sex with menK01AA028199 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI KNOX, JUSTIN · 2020 to 2024
$865k
Neutrophil-driven mucosal dysfunction in SIV/malaria co-infectionR21OD031435 · OD · TULANE UNIVERSITY OF LOUISIANA · PI MANUZAK, JENNIFER · 2021 to 2022
$680k
Social environmental drivers of stimulant use and its impact on HIV prevention and treatment in Black men who have sex with menR21DA053156 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI KNOX, JUSTIN · 2021 to 2022
$472k
NCATS NIH HHS UL1 TR002384NIAAA NIH HHS K01 AA028199NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069423NIAID NIH HHS UM1 AI069432NIAID NIH HHS UM1 AI106701NICHD NIH HHS R01 HD108015NIDA NIH HHS R01 DA054553NIDA NIH HHS R21 DA053156NIH HHS P51 OD011104NIH HHS R21 OD031435
6 · The paper itself

Abstract

Background: Conflicting evidence exists on the impact of cannabis use on antiretroviral therapy (ART) adherence among people with human immunodeficiency virus (PWH). We leveraged data collected among older PWH to characterize longitudinal associations between cannabis use and ART adherence. Methods: AIDS Clinical Trials Group (ACTG) A5322 study participants were categorized as <100% (≥1 missed dose in past 7 days) or 100% (no missed doses) ART adherent. Participants self-reported current (past month), intermittent (past year but not past month), and no cannabis (in past year) use at each study visit. Generalized linear models using generalized estimating equations were fit and inverse probability weighting was used to adjust for time-varying confounders and loss to follow-up. Results: Among 1011 participants (median age, 51 years), 18% reported current, 6% intermittent, and 76% no cannabis use at baseline; 88% reported 100% ART adherence. Current cannabis users were more likely to be <100% adherent than nonusers (adjusted risk ratio [aRR], 1.53 [95% CI, 1.11-2.10]). There was no association between ART adherence and current versus intermittent (aRR, 1.39 [95% CI, .85-2.28]) or intermittent versus no cannabis use (aRR, 1.04 [95% CI, .62-1.73]). Conclusions: Among a cohort of older PWH, current cannabis users had a higher risk of <100% ART adherence compared to nonusers. These findings have important clinical implications as suboptimal ART adherence is associated with ART drug resistance, virologic failure, and elevated risk for mortality. Further research is needed to elucidate the mechanisms by which cannabis use decreases ART adherence in older PWH and to advance the development of more efficacious methods to mitigate nonadherence in this vulnerable population.

Indexed as

adherenceagingantiretroviral therapycannabisHIV

Identifiers

PMID36726540
PMCPMC9879711
OpenAlexW4313704488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.